NewEdge Advisors’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$847K Buy
3,704
+1,292
+54% +$234K ﹤0.01% 1769
2026
Q1
$322K Buy
2,412
+2,386
+9,177% +$380K ﹤0.01% 2291
2025
Q4
$4.51K Sell
26
-2,250
-99% -$370K ﹤0.01% 3706
2025
Q3
$436K Buy
2,276
+1,403
+161% +$258K ﹤0.01% 1917
2025
Q2
$260K Sell
873
-233
-21% -$73.2K ﹤0.01% 2094
2025
Q1
$364K Buy
1,106
+277
+33% +$83.7K ﹤0.01% 1768
2024
Q4
$241K Sell
829
-33
-4% -$10.2K ﹤0.01% 1991
2024
Q3
$297K Sell
862
-210
-20% -$69.3K ﹤0.01% 1803
2024
Q2
$319K Sell
1,072
-1,685
-61% -$572K ﹤0.01% 1684
2024
Q1
$1.13M Buy
2,757
+121
+5% +$46.9K 0.01% 947
2023
Q4
$969K Buy
2,636
+124
+5% +$43.7K 0.01% 947
2023
Q3
$824K Sell
2,512
-153
-6% -$48.2K 0.01% 953
2023
Q2
$803K Buy
+2,665
New +$766K 0.01% 966
2023
Q1
Sell
-321
Closed -$42K 3871
2022
Q4
$42K Buy
+321
New +$109K ﹤0.01% 1793

Other funds holding MOH

NewEdge Advisors's MOH Position: Q2 2026 in Review

NewEdge Advisors increased its Molina Healthcare (MOH) stake by 54% in Q2 2026, buying an estimated $234K and bringing the position to 3,704 shares worth $847K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

NewEdge Advisors first reported a position in MOH in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.13M in Q1 2024. 601 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • NewEdge Advisors held 3,704 shares of Molina Healthcare worth $847K as of Q2 2026.
  • NewEdge Advisors bought 1,292 Molina Healthcare shares in Q2 2026, an estimated $234K.
  • Molina Healthcare made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1769 holding.
  • NewEdge Advisors first reported a position in Molina Healthcare in Q4 2022 and has held it in 14 quarters since.
  • NewEdge Advisors's Molina Healthcare position peaked at $1.13M in Q1 2024.
  • 601 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.